Immunoserological parameters in SLE: High-avidity anti-dsDNA detected by ELISA are the most closely associated with the disease activity

Clinical Rheumatology

Volumn 32, Issue 11, 2013, Pages 1619-1626

  Andrejevic, Sladjana ^a   Jeremic, Ivica ^a   Sefik Bukilica, Mirjana ^a   Nikolic, Milos ^a   Stojimirovic, Biljana ^a   Bonaci Nikolic, Branka ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Avidity; Complement; dsDNA; SLE; SLEDAI

Indexed keywords

COMPLEMENT COMPONENT C1Q ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DOUBLE STRANDED DNA ANTIBODY; HISTONE ANTIBODY; NUCLEOSOME ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTHRALGIA; ARTHRITIS; ARTHROPATHY; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CRITHIDIA; CYTOPENIA; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; POLYSEROSITIS; PRIORITY JOURNAL; RISK FACTOR; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC THERAPY;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; COMPLEMENT SYSTEM PROTEINS; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 84886261563     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-013-2330-3     Document Type: Article

References (41)

1. Kramers C, Hylkema MN, Vanbruggen MCJ, Vandelagemaat R, Dijkman HBPM, Assmann KJM, Smeenk RJT, Berden JHM (1994) Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular-basement-membrane in-vivo. J Clin Invest 94:568-577
2. Hahn BH (1998) Antibodies to DNA. N Eng J Med 338:1359-1368 (Pubitemid 28216666)
3. Amoura Z, Koutouzov S, Piette JC (2000) The role of nucleosomes in lupus. Curr Opin Rheumatol 12:369-373
4. Viard JP, Choquette D, Chabre H, Slama FB, Primo J, Letrait M, Venot A, Jacob L (1992) Anti-histone reactivity in systemic lupus erythematosus sera: a disease activity index linked to the presence of DNA: anti-DNA immune complexes. Autoimmunity 12:61-68
5. Horák P, Heřmanová Z, Zadražil J, Ciferská H, Ordeltová M, Kusá L, Žurek M, Tichý T (2006) C1q complement component and antibodies reflect SLE activity and kidney involvement. Clin Rheumatol 25:532-536 (Pubitemid 44143752)
6. Mok CC, Ho LY, Leung HW, Wong LG (2010) Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus. Transl Res 156:320-325
7. Schiffer LE, Hussain N, Wang X, Huang W, Sinha J, Ramanujam M, Davidson A (2002) Lowering anti-dsDNA antibodies-what's new? Lupus 11:885-894 (Pubitemid 36069985)
8. Isenberg D, Smeenk R (2002) Clinical laboratory assays for measuring anti-dsDNA antibodies. Where are we now? Lupus 11:797-800 (Pubitemid 36069975)
9. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rithfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277 (Pubitemid 13221242)
10. Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29:288-291 (Pubitemid 34118775)
11. Villegas-Zambrano N, Martínez-Taboada VM, Bolívar A, San Martin M, Alvarez L, Marin MJ, López-Hoyos M (2009) Correlation between clinical activity and serological markers in a wide cohort of patients with systemic lupus erythematosus: an eight-year prospective study. Ann NY Acad Sci 1173:60-66
12. Toubi E, Rosner I, Rozenbaum M, Kessel A, Golan TD (2000) The benefit of combining hydroxychloroquine and quinacrine in the treatment of SLE patients. Lupus 9:92-95 (Pubitemid 30171104)
13. Min D-J, Kim S-J, Park S-H, Seo Y-I, Kang H-J, Kim W-U, Cho C-S, Kim H-Y (2002) Anti-nucleosome antibody: significance in lupus patients lacking anti-double-stranded DNA antibody. Clin Exp Rheum 20:13-18 (Pubitemid 34213727)
14. Petri M, Buyon J, Kim M (1999) Classification and definition of major flares in SLE clinical trials. Lupus 8:685-91 (Pubitemid 29520536)
15. Swaak AJ, Aarden LA, Statius van Eps LW, Feltkamp TE (1979) Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum 22:226-235 (Pubitemid 9157358)
16. Reveille JD (2004) Predictive value of autoantibodies for activity of systemic lupus erythematosus. Lupus 13:290-297 (Pubitemid 38788485)
17. López-Hoyos M, Cabeza R, Martínez-Taboada VM, Crespo J, SanSegundo D, Blanco R, López-Escribano H, Peña M, Rodrigez-Valverde V (2005) Clinical disease activity and titers of anti-dsDNA antibodies measured by an automated immunofluorescence assay in patients with systemic lupus erythematosus. Lupus 14:505-509 (Pubitemid 41161079)
18. Chen C-Y, Tseng H-M, Chen L-C, Tsao C-H, Kuo M-L, Ou L-S, Huang J-L (2003) Use of a new fluorescence immunoassay to detect anti-dsDNA antibodies is more correlated with disease activity and complement than the ELISA method in SLE patients. Lupus 12:266-273 (Pubitemid 36458656)
19. Winfield JB, Faiferman I, Koffler D (1977) Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis. J Clin Invest 59:90-96 (Pubitemid 8018043)
20. Villalta D, Romelli PB, Savina C, Bizzaro N, Tozzoli R, Tonutti E, Ghirardello A, Doria A (2003) Anti-dsDNA antibody avidity determination by a simple reliable ELISA method for SLE diagnosis and monitoring. Lupus 12:31-36 (Pubitemid 36172660)
21. Ghirardello A, Villalta D, Morozzi G et al (2011) Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study. Clin Exp Rheum 29:50-56
22. Jaekel HP, Trabandt A, Grobe N, Werle E (2006) Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis. Lupus 15:335-345 (Pubitemid 44032708)
23. Kim KH, Han JY, Kim JM, Lee SW, Chung WT (2007) Clinical significance of ELISA positive and immunofluorescence negative anti-dsDNA antibody. Clin Chim Acta 380:182-185 (Pubitemid 46509629)
24. Antico A, Platzgummer S, Bassetti D, Bizzaro N, Tozzoli R, Villalta D (2010) Diagnosing systemic lupus erythematosus: new-generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternative to the Farr technique and the Crithidia luciliae immunofluorescence test. Lupus 19:906-912
25. Fiegel F, Buhl A, Jaekel HP, Werle E, Schmolke M, Ollert M, Luppa PB (2010) Autoantibodies to double-stranded DNA - intermethod comparison between four commercial immunoassays and a research biosensor-based device. Lupus 19:957-964
26. Wasmuth J-C, Grün B, Homrighausen A, Spangler U (2004) ROC analysis comparison of three assays for the detection of antibodies against double-stranded DNA in serum for the diagnosis of systemic lupus erythematosus. Clin Chem 50:2169-2171 (Pubitemid 39425863)
27. Saisoong S, Eiam-Ong S, Hanvivatvong O (2006) Correlations between antinucleosome antibodies and anti-double-stranded DNA antibodies, C3, C4, and clinical activity in lupus patients. Clin Exp Rheumatol 24:51-58
28. Su Y, Jia RL, Han I, Li ZG (2007) Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus. Clin Immunol 122:115-120 (Pubitemid 46026699)
29. Ghirardello A, Doria A, Zampieri S, Tarricone E, Tozzoli R, Villalta D, Bizzaro N, Piccolo A, Gambari PF (2004) Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patients. J Autoimmun 22:235-240 (Pubitemid 38369184)
30. Manson JJ, Ma A, Rogers P, Mason LJ, Berden JH, van der Vlag J, D'Cruz DP, Isenberg DA, Rahman A (2009) Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study. Arthritis Res Ther 11:R154
31. Shabana AA, El-Ghawet AE, Machaly SA, Abu Hashim EM (2009) Anti-chromatin and anti-histone antibodies in Egyptian patients with systemic lupus erythematosus. Clin Rheumatol 28:673-678
32. Ravirajan CT, Rowse L, MacGowan JR, Isenberg DA (2001) An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study. Rheumatology (Oxford) 40:1405-1412
33. Schett G, Smolen J, Zimmermman C, Hiesberger H, Hoefler E, Fournel S, Muller S, Rubin RL, Steiner G (2002) The autoimmune response to chromatin antigens in systemic lupus erythematosus: autoantibodies against histone H1 are highly specific marker for SLE associated with increased disease activity. Lupus 11:704-715 (Pubitemid 35408075)
34. Nauta AJ, Trouw LA, Daha MR, Tijsma O, Nieuwland R, Schwaeble WJ, Gingras AR, Mantovani A, Hack EC, Roos A (2002) Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur J Immunol 32:1726-1736 (Pubitemid 34679160)
35. Flierman R, Daha MR (2007) Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis - a hypothesis. Mol Immunol 44:133-138 (Pubitemid 44754840)
36. Trouw LA, Groeneveld TW, Seelen MA, Dujis JM, Bajema IM, Prins FA, Kishore U, Salant DJ, Verebeek JS, van Kooten C, Daha MR (2004) Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J Clin Invest 114:679-688 (Pubitemid 39578758)
37. Tsirogianni A, Pipi E, Soufleros K (2009) Relevance of anti-C1q autoantibodies to lupus nephritis. Ann NY Acad Sci 1173:243-251
38. Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G (2003) Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement. Clin Rheumatol 22:271-278 (Pubitemid 37483619)
39. O'Flynn J, Flierman R, van der Pol P, Rops A, Satchell SC, Mathieson PW, van Kooten C, van der Vlag J, Berden JH, Daha MR (2011) Nucleosomes and C1q bound to glomerular endothelial cells serve as targets for autoantibodies and determine complement activation. Mol Immunol 49:75-83
40. Mayer OC, Nicaise-Roland P, Cadoudal N, Grootenboer-Mignot S, Palazzo E, Hayem G, Dieudé P, Chollet-Martin S (2009) Anti-C1q antibodies antedate patient active glomerulonephritis in patients with systemic lupus erythematosus. Arthritis Res Ter 11:R87
41. Kavanaugh AF, Solomon DH (2002) Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests. Arthritis Rheum (Arthritis Care and Research) 47:546-555 (Pubitemid 35291379)